Evidence map›Paper›PMID 41577697›Full record

ArticleNature communications2026

Combinatory differentiation of human induced pluripotent stem cells generates functional thymic epithelium driving dendritic cell and CD4/CD8 T cell development.

Nathan Provin, Manon d'Arco, Antoine Le Bozec, Erwan Kervagoret, Alexandre Bruneau, Lucas Brusselle, Cynthia Fourgeux, Jeremie Poschmann, Philippe Hulin, Pierre Maminirina and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Rediscovering the human thymus through cutting-edge technologies.The Journal of experimental medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nathan Provin *Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000, Nantes, France. provin.nathan@gmail.com.
Manon d'Arco *Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000, Nantes, France.ORCID 0009-0002-7239-4435
Antoine Le BozecNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000, Nantes, France.
Erwan KervagoretNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000, Nantes, France.
Alexandre BruneauNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000, Nantes, France.
Lucas BrusselleNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000, Nantes, France.
Cynthia FourgeuxNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000, Nantes, France.ORCID 0000-0002-3330-7530
Jeremie PoschmannNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000, Nantes, France.ORCID 0000-0002-9613-5297
Philippe HulinNantes Université, CHU Nantes, INSERM, CNRS, BioCore, F-44000, Nantes, France.
Pierre MaminirinaCHU Nantes, Nantes Université, Department of Pediatric and Congenital Cardiac Surgery, Nantes, France.
Olivier BaronCHU Nantes, Nantes Université, Department of Pediatric and Congenital Cardiac Surgery, Nantes, France.
Xavier SaulquinNantes Université, INSERM, CNRS, Center for Research in Cancerology and Integrated Immunology Nantes-Angers, 44035, Nantes, France.
Carole GuillonneauNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000, Nantes, France.
Laurent DavidNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000, Nantes, France.ORCID 0000-0003-3594-0353
Matthieu GiraudNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000, Nantes, France. matthieu.giraud@inserm.fr.ORCID 0000-0002-1208-9677

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-19-RAR4-0011-05FRMla Fondation pour la Recherche MédicaleNational Organization for Rare Disorders (National Organization for Rare Disorders, Inc.) 22001RFI Bioregate
6 · The paper itself

Abstract

The thymus educates thymocytes through a selection process mediated by thymic epithelial cells (TECs). Recent advances have made the generation of T lymphocytes from induced pluripotent stem cells (iPSc) a promising therapeutic strategy. However, current approaches often fail to replicate the thymic niche, leading to impaired T cell generation. Here we address the production of functional mature iPSc-derived TECs supporting in vitro T cell generation. We optimize thymic lineage differentiation through an unbiased multifactorial experimental design. By modulating specific signaling pathways, we generate progenitors that mature into medullary and cortical TECs. Co-culture with primary hematopoietic progenitors in a 3D thymic organoid setup induces their differentiation into CD4

Indexed as

CD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationDendritic CellsInduced Pluripotent Stem CellsThymus GlandCell LineageCells, CulturedCoculture TechniquesEpithelial CellsHumansOrganoids

Identifiers

PMID41577697
PMCPMC12932823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.